Qiagen's Revenues Rise 22 Percent in Q4, Eclipse $1B Mark for FY 2009

Qiagen's revenues were driven by its molecular diagnostics sales, which now account for nearly 50 percent of the firm's total sales.

Qiagen Licenses Biomarker IP from Johns Hopkins

The company plans to use the PI3K gene to develop companion diagnostics for cancer drugs.

CDC to Fund Genomics Knowledge Center

The $1.5 million grant will start a center to review and generate evidence on genomics applications.

DNAVision Adds Illumina HiSeq to Service Offerings

The HiSeq 2000 joins DNAVision's other next-gen sequencing platforms that are used in its genomics services offerings.

EU, India to Partner on Joint Research Efforts

The New Indigo project will involve Indian and EU state partners on bioinformatics, biomarker, and diagnostics studies.

Institute for Systems Biology Mulls Expansion, Focusing on P4 Efforts

ISB Co-founder and President Leroy Hood told GenomeWeb Daily News in a wide-ranging interview that the institute is considering a consolidation and expansion of its facilities. He also provided updates on a variety of ongoing collaborations focused on personalized medicine.

Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion

Varian's Q1 revenues dipped 3 percent due to lower sales volume and lower average selling prices of certain analytical instruments products, the firm said.

Denator Inks Swiss Distribution Pact

Bucher Biotec will market and service Denator's protein and peptide sample stabilization technology in Switzerland.

HHS Advisory Group Proposes Gene Patent Limits, Riles Industry

The SACGHS report advises changes in the law to release diagnostic nucleic acid-based tests and genetics research from infringement liability.

Abbott Files US Suit Against Qiagen Over HPV IP Dispute

Abbott wants the court to compel Qiagen to participate in arbitration over a licensing deal covering HPV IP.

In Brief This Week: Bio-Rad Laboratories; TGen, Van Andel Research Institute; Infosys, Elan; Dotmatix, Boehringer Ingelheim

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Tecan to Manufacture Enigma Diagnostics' Instruments

Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.

HDC to Partner with Saint Vincent Pancreatic Cancer Center

Health Discovery Corporation has entered into an exclusive agreement with St. Vincent Catholic Medical Centers to come up with biomarkers for use in early diagnostic tests for pancreatic cancer.